3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
4
Phase 1/2
2
Phase 2
1
Status
Completed
60
Terminated
38
Unknown
9
Withdrawn
8
Recruiting
6
Active not recruiting
5
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Interventions
Carboplatin
79
Cisplatin
74
Bevacizumab
62
Radiotherapy
59
Drug Therapy
57
Capecitabine
57
Oxaliplatin
56
tislelizumab
54
toripalimab
45
Paclitaxel
44
Gemcitabine
43
pembrolizumab
40
anlotinib
40
Specimen Handling
39
sintilimab
37
Cyclophosphamide
34
130-nm albumin-bound paclitaxel
34
Injections
30
Pemetrexed
28
camrelizumab
26
Surgical Procedures, Operative
26
Magnetic Resonance Spectroscopy
25
lenvatinib
24
apatinib
23
Docetaxel
23
Etoposide
22
S 1 (combination)
21
Fluorouracil
21
Immune Checkpoint Inhibitors
20
Biopsy
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Not yet recruiting
×
Interleukin-2
×
Clear all
NCT05810792
2023-11-22
PANCEP-1
Sahlgrenska University Hospital
Phase 2
Not yet recruiting
50 enrolled